Pharma Deals

Cell therapy (CT), stem cell (SC) and regenerative medicine (RM) - intelligence ... 

Collaborations, joint ventures, co-development, licensing, option and partnering agreements and deals are listed.

The recent wave seem to be OPTION deals … as CT, SC and RM companies … “Turn-over-the-cards” of their advancing studies – for this “option format” to be established.  There have been upfront dollars but it is still back-end and to-the-future monetary arrangements that come into play!

Asset swaps and other types of strategic alliances have become particularly prominent. Companies are looking at what they do well and where they are weak, and then sell or turn-over product platforms to Pharma that can complement those areas. Such deal structures can conserve cash and help “some” corporations avoid painful adjustments.

NOTHING it seems <lately> is straightforward … there’s some very creative “structures” that have been executed!